Cytiva India Profile
Key Indicators
- Authorised Capital ₹ 62.78 Cr
as on 17-11-2024
- Paid Up Capital ₹ 62.00 Cr
as on 17-11-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Cytiva India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 62.78 Cr and a paid-up capital of Rs 62.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cytiva India Private Limited India is Abhishek Supekar as COMPANY SECRETARY. Satya Udandravu, Madhusudan Jugdar, and Ramakrishna Kumar serve as directors at the Company.
- CIN/LLPIN
U29100PN2022FTC210393
- Company No.
210393
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
15 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cytiva India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhishek Supekar | Company Secretary | 24-Jan-2024 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satya Udandravu | Director | 02-Feb-2023 | Current |
Madhusudan Jugdar | Director | 15-Apr-2022 | Current |
Ramakrishna Kumar | Director | 13-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of Cytiva India.
Cytiva India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Cytiva India?
In 2023, Cytiva India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Hyclone Life Sciences Solutions India Private LimitedActive 5 years 4 months
Satya Udandravu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cytiva India?
Cytiva India has a workforce of 37 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytiva India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytiva India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.